HEALTH BY SCIENCE LTD CIC

Company limited by guarantee

Company Registration Number:
SC557048 (Scotland)

Unaudited statutory accounts for the year ended 28 February 2023

Period of accounts

Start date: 1 March 2022

End date: 28 February 2023

HEALTH BY SCIENCE LTD CIC

Contents of the Financial Statements

for the Period Ended 28 February 2023

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

HEALTH BY SCIENCE LTD CIC

Directors' report period ended 28 February 2023

The directors present their report with the financial statements of the company for the period ended 28 February 2023

Principal activities of the company

The company's principal activity during the year continued to be Physiotherapy.

Additional information

As at 28.02.23, the directors collectively owed the directors loan account £17,939.56.



Directors

The directors shown below have held office during the whole of the period from
1 March 2022 to 28 February 2023

Stuart Maytham
Alex Nairn
Ross Marwick


The directors shown below have held office during the period of
24 February 2023 to 28 February 2023

Amanda Jones
Judith Lane


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
17 November 2023

And signed on behalf of the board by:
Name: Stuart Maytham
Status: Director

HEALTH BY SCIENCE LTD CIC

Profit And Loss Account

for the Period Ended 28 February 2023

2023 2022


£

£
Turnover: 322,081 256,203
Cost of sales: ( 58,210 ) ( 8,887 )
Gross profit(or loss): 263,871 247,316
Administrative expenses: ( 294,676 ) ( 278,653 )
Other operating income: 17,307 48,469
Operating profit(or loss): (13,498) 17,132
Interest payable and similar charges: ( 897 ) ( 896 )
Profit(or loss) before tax: (14,395) 16,236
Profit(or loss) for the financial year: (14,395) 16,236

HEALTH BY SCIENCE LTD CIC

Balance sheet

As at 28 February 2023

Notes 2023 2022


£

£
Fixed assets
Tangible assets: 3 35,161 38,052
Total fixed assets: 35,161 38,052
Current assets
Debtors: 4 27,393 35,468
Cash at bank and in hand: 23,071 31,997
Total current assets: 50,464 67,465
Creditors: amounts falling due within one year: 5 ( 20,910 )
Net current assets (liabilities): 29,554 67,465
Total assets less current liabilities: 64,715 105,517
Creditors: amounts falling due after more than one year: 6 ( 12,532 ) ( 39,085 )
Accruals and deferred income: ( 146 )
Total net assets (liabilities): 52,037 66,432
Members' funds
Profit and loss account: 52,037 66,432
Total members' funds: 52,037 66,432

The notes form part of these financial statements

HEALTH BY SCIENCE LTD CIC

Balance sheet statements

For the year ending 28 February 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 17 November 2023
and signed on behalf of the board by:

Name: Stuart Maytham
Status: Director

The notes form part of these financial statements

HEALTH BY SCIENCE LTD CIC

Notes to the Financial Statements

for the Period Ended 28 February 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Turnover is measured at the fair value of the consideration received or receivable, net ofdiscounts and value added taxes. Turnover includes revenue earned from the sale of goods andfrom the rendering of services. Turnover from the sale of goods is recognised when thesignificant risks and rewards of ownership of the goods have transferred to the buyer. Turnoverfrom the rendering of services is recognised by reference to the stage of completion of thecontract. The stage of completion of a contract is measured by comparing the costs incurred forwork performed to date to the total estimated contract costs.

    Tangible fixed assets depreciation policy

    Tangible fixed assets are measured at cost less accumulative depreciation and any accumulativeimpairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land,at rates calculated to write off the cost, less estimated residual value, of each asset evenly overits expected useful life, as follows:Plant and machinery over 5 yearsFixtures, fittings, tools and equipment over 5 years

    Other accounting policies

    A current tax liability is recognised for the tax payable on the taxable profit of the current and pastperiods. A current tax asset is recognised in respect of a tax loss that can be carried back torecover tax paid in a previous period. Deferred tax is recognised in respect of all timingdifferences between the recognition of income and expenses in the financial statements and theirinclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognisedonly to the extent that it is probable that they will be recovered against the reversal of deferredtax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and lawsthat have been enacted or substantively enacted by the reporting date and that are expected toapply to the reversal of the timing difference, except for revalued land and investment propertywhere the tax rate that applies to the sale of the asset is used. Current and deferred tax assetsand liabilities are not discounted.

HEALTH BY SCIENCE LTD CIC

Notes to the Financial Statements

for the Period Ended 28 February 2023

  • 2. Employees

    2023 2022
    Average number of employees during the period 5 8

HEALTH BY SCIENCE LTD CIC

Notes to the Financial Statements

for the Period Ended 28 February 2023

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 March 2022 42,646 16,955 59,601
Additions 1,677 1,677
Disposals
Revaluations
Transfers
At 28 February 2023 44,323 16,955 61,278
Depreciation
At 1 March 2022 15,605 5,944 21,549
Charge for year 2,872 1,696 4,568
On disposals
Other adjustments
At 28 February 2023 18,477 7,640 26,117
Net book value
At 28 February 2023 25,846 9,315 35,161
At 28 February 2022 27,041 11,011 38,052

HEALTH BY SCIENCE LTD CIC

Notes to the Financial Statements

for the Period Ended 28 February 2023

4. Debtors

2023 2022
£ £
Trade debtors 3,398 475
Other debtors 23,995 34,993
Total 27,393 35,468

HEALTH BY SCIENCE LTD CIC

Notes to the Financial Statements

for the Period Ended 28 February 2023

5. Creditors: amounts falling due within one year note

2023
£
Taxation and social security 10,233
Other creditors 10,677
Total 20,910

HEALTH BY SCIENCE LTD CIC

Notes to the Financial Statements

for the Period Ended 28 February 2023

6. Creditors: amounts falling due after more than one year note

2023 2022
£ £
Bank loans and overdrafts 12,532 39,085
Total 12,532 39,085

HEALTH BY SCIENCE LTD CIC

Notes to the Financial Statements

for the Period Ended 28 February 2023

7. Loans to directors

Name of director receiving advance or credit:
Description of the transaction:
Directors loan being repaid to the business.
£
Balance at 28 February 2022 9,320
Advances or credits made: 8,619
Advances or credits repaid:
Balance at 28 February 2023 17,939

As at 28.02.23, the directors collectively owed the directors loan account £17,939.56.

COMMUNITY INTEREST ANNUAL REPORT

HEALTH BY SCIENCE LTD CIC

Company Number: SC557048 (Scotland)

Year Ending: 28 February 2023

Company activities and impact

This year we have doubled our rehabilitation Thrive Classes from 5 to 10 helping over 50 people with long term physical conditions such as stroke survivors, cancer survivors and people living with Parkinson's Disease. We have been able to subsidise the cost of over 75% of these places by reinvesting our profits back into this class.

Consultation with stakeholders

We consult with our stakeholders every quarter to measure our social impact and to critically reflect on how we can improve our services. We were informed that our classes could be improved by providing hot drinks for after the classes, to help create more of a sense of community and reduce social isolation. We have now introduced this and it is working very well.

Directors' remuneration

Ross Marwick received £35,946.51Stuart Maytham received £20,071.14Alex Nairn received £36,376.81

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
17 November 2023

And signed on behalf of the board by:
Name: Stuart Maytham
Status: Director